期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

妊娠期哮喘的药物治疗及其安全性 被引量：2

下载PDF
导出
摘要 哮喘在全世界范围内是最常见的慢性病之一，也是妊娠妇女常见并发的慢性病，据报道，1997～2001年美国妊娠妇女哮喘的发病率为3．7％-8．4％。哮喘无论是对孕妇还是胎儿都会造成严重的医学问题。妊娠期间很好地控制哮喘对孕妇及其胎儿的健康都很重要。
作者 任静恩 王强
机构地区 首都医科大学燕京医学院附属北京平谷医院药剂科 中国医学科学院中国协和医科大学北京协和医院
出处 《中国药师》 CAS 2009年第6期804-806,共3页 China Pharmacist
关键词 妊娠期 哮喘 药物治疗
分类号 R562.25 [医药卫生—呼吸系统]
  • 相关文献

参考文献11

二级参考文献14

  • 1[4]首都儿科研究所哮喘防治与教育中心(译).全球哮喘防治的创议修订版[M].2002.
  • 2[5]Wenzel S.Severe asthma in adults[J].Am J Respir Crit Care Med,2005,172:149.
  • 3[6]Murphy K E.Asthma:versatile treatment for a variable disease[J].J Asthma,2005,42:149.
  • 4Global initiative for asthma: global strategy for asthma management and prevention NHILBI/WHO workshop report[ J ]. NIH publication No. 02, 2002,3659.
  • 5Barnes PJ, Pedersen S, Busse WW.Efficacy and safety of inhaled corticosteroids [ J ]. Am J Respir Crit Care Med, 1998,157 : S1 - 53.
  • 6Todd GRG, Acerini C, Ross- Russell R,et al. National survey (UK) of acute adrenal crisis due to inhaled corticosteroids [ J ]. J Allergy Clin Immunol,2002,109(1 pt2) :S252.
  • 7Mcivor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma[J]. Am J Respir Crit Care Med,1988,158:924 - 930.
  • 8Jenkins C, Woolcock AJ, Saarelainen P, et al.Salmetero/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma[J].Respir Med, 2000,94:715:723.
  • 9Storms W, Michele TM, Knorr B, et al.Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients age > or = 6 years[J]. Clin Exp Allergy,2001,31:77 -78.
  • 10Stempel DA, Stanford RH, McLaughlin T, et al. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast [ J ]. Respir Med, 2001,95 : 227-234.

共引文献43

同被引文献15

  • 1Louik C, Schatz M, Hernemdez-Dlaz S, et al. Asthma in pregnancy and its pharmacologic treatment [ J ]. Ann Allergy Asthma Immunol, 2010,105(2) :110-7.
  • 2National Ashma Education and Prevention Program Ashma and Preg- nancy Working Group expert panel report. Managing ashma during pregnancy: recommendations for pharmacologic treament 2004 up- date[J]. J Allergy Clin Immunol 2005 ,115( 1 ) :34.
  • 3Dombrowski MP, Schatz M. Asthma in pregnancy[ J]. Clin Obstet Gyneco1,2010,53 (2) :301 - 10.
  • 4Breton MC, Beanchesne MF, Lemire C, etal. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy [ J ]. Allergy Clin Immunol, 2010,126 (4) :772 -777. e2.
  • 5Hodyl NA, et al. Fetal Glucocortieoid Regulated Pathways are not Affected by Inhaled Corticosteroid use for Asthma During Pregnancy [J]. Am J Respir Crit Care Med,2010,8. [ Epub ahead of print].
  • 6Mamazy JA, Schatz M. Treatment of ashma during pregnancy and perinatal outcomes [ J ]. Curr Opin Allergy Clin Immunol, 2005,5 C3) :229 -33.
  • 7国家药典委员会.临床用药须知(化学药和生物制品卷)[S].2005年版.北京:人民卫生出版社,2005:250-251,245.
  • 8Dombrowski MP,$chatz M.Asthma in pregnancy[J].Clin Obstet Gynecol, 2010,53(2):301-310.
  • 9Breton MO,Beauchesne MF,Lemi ~ re C,et al.P~isk of perinatal mortality associated with inhaled cortieosteroid use for the treatment of asthma during pregnancy[J]. Allergy Olin Immunol, 201 O, 126 (4): : 772-777, e 2.
  • 10张怡,陈培.布地奈德在儿童支气管哮喘的疗效观察[J].四川医学,2008,29(12):1654-1656. 被引量：15

二级引证文献13

中国药师
2009年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部